Transvenous valve-in-valve replacement preserving the function of a transvalvular defibrillator lead

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 7, 2014, Pages 1148-1152

  De Meester, Pieter ^a   Budts, Werner ^a   Gewillig, Marc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Internal cardiac defibrillator; Lead protection; Percutaneous intervention; Tricuspid valve

Indexed keywords

POLITEF;

ADULT; ARTERIAL TRUNK; ARTICLE; CARPENTIER EDWARDS BIOPROSTHESIS; CASE REPORT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; HEART ATRIUM ENLARGEMENT; HEART RIGHT VENTRICLE FAILURE; HEART VALVE REPLACEMENT; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERNAL DEFIBRILLATOR; LUNG ARTERY BANDING; MALE; PERCUTANEOUS AORTIC VALVE; TRANSVENOUS VALVE IN VALVE REPLACEMENT; TREATMENT RESPONSE; TRICUSPID VALVE PROSTHESIS; TRICUSPID VALVE STENOSIS; VALVE DETERIORATION; ADVERSE EFFECTS; ANGIOGRAPHY; CENTRAL VENOUS CATHETERIZATION; FOLLOW UP; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; JUGULAR VEIN; PROCEDURES; TACHYCARDIA, VENTRICULAR;

ADULT; ANGIOGRAPHY; CATHETERIZATION, CENTRAL VENOUS; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY, DOPPLER; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; JUGULAR VEINS; MALE; TACHYCARDIA, VENTRICULAR; TRICUSPID VALVE STENOSIS;

EID: 84912028446     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25451     Document Type: Article

References (10)

1. Roberts P, Spina R, Vallely M, Wilson M, Bailey B, Celermajer DS. Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circ Cardiovasc Interv 2010;3:e14-e15.
2. Gaia DF, Palma JH, de Souza JA, Buffolo E. Tricuspid transcatheter valve-in-valve: An alternative for high-risk patients. Eur J Cardiothorac Surg 2012;41:696-698.
3. Weich H, Janson J, van Wyk, J, Herbst P, le Roux P, Doubell A. Transjugular tricuspid valve-in-valve replacement. Circulation 2011;124:e157-e160.
4. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007;115:2474-2480.
5. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, et al. Transvenous defibrillation leads: High incidence of failure during longterm follow-up. J Cardiovasc Electrophysiol 2003;14:38-43.
6. Uijlings R, Kluin J, Salomonsz R, Burgmans M, Cramer MJ. Pacemaker lead-induced severe tricuspid valve stenosis. Circ Heart Fail 2010;3:465-467.
7. Heaven DJ, Henein MY, Sutton R. Pacemaker lead related tricuspid stenosis: A report of two cases. Heart 2000;83:351-352.
8. Smith MC, Love CJ. Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol 2008;31:736-752.
9. Winter J, Heil JE, Schumann C, Lin Y, Schannwell CM, Michel U, Schipke JD, Schulte HD, Gams E. Effect of implantable cardioverter/defibrillator lead placement in the right ventricle on defibrillation energy requirements a combined experimental and clinical study. Eur J Cardio-Thorac Surg 1998;14:419-425.
10. Maines M, Landolina M, Lunati M, Lonardi G, Pappone A, Proclemer A, Zanotto G, Santini M, Varbaro A, Vimercati M, et al. Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT. Pacing Clin Electrophysiol 2010;33:64-73.